Stockscreener 앱 받기
24.98
4.28%
1.025
전일 마감가:
$23.95
열려 있는:
$24.14
하루 거래량:
33,607
Relative Volume:
0.03
시가총액:
$39.96M
수익:
-
순이익/손실:
$-38.35M
주가수익비율:
-17.22
EPS:
-1.45
순현금흐름:
$-36.91M
1주 성능:
+21.83%
1개월 성능:
-16.75%
6개월 성능:
+613.57%
1년 성능:
+439.42%
1일 변동 폭
$23.77
$26.30
1주일 범위
$20.21
$26.30
52주 변동 폭
$2.01
$38.33
Galecto Inc Stock (GLTO) Company Profile
명칭
Galecto Inc
전화
45-70-70-52-10
주소
75 STATE STREET, BOSTON
GLTO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLTO
Galecto Inc
|
24.98 | 38.32M | 0 | -38.35M | -36.91M | -1.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | Leerink Partners | Outperform |
| 2025-12-01 | 개시 | Guggenheim | Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-11-23 | 개시 | BofA Securities | Buy |
| 2020-11-23 | 개시 | Credit Suisse | Outperform |
| 2020-11-23 | 개시 | SVB Leerink | Outperform |
모두보기
Galecto Inc 주식(GLTO)의 최신 뉴스
Galecto, Inc. (NASDAQ:GLTO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Movement Recap: Is Galecto Incs ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - baoquankhu1.vn
Galecto (GLTO) Price Target Increased by 13.89% to 41.82 - Nasdaq
Investment Recap: Can Galecto Inc stock double in next 5 yearsEarnings Recap Report & Safe Entry Point Alerts - Bộ Nội Vụ
Galecto on track to submit IND for mutCALR antibody by mid-2026 - Investing.com Nigeria
Galecto (GLTO) Sets Ambitious Clinical Milestones for 2026 - GuruFocus
Galecto Showcases New mutCALR MPN Pipeline at JPM - TipRanks
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones - The Manila Times
Galecto, Inc. Reports Strategic Shift and Financial Results - MSN
Galecto Completes Acquisition of Damora Therapeutics - MSN
Galecto (NASDAQ:GLTO) Upgraded at Leerink Partnrs - Defense World
What risks investors should watch in Galecto Inc. stock2025 Year in Review & Consistent Growth Equity Picks - ulpravda.ru
Is Galecto Inc. stock attractive for hedge fundsJuly 2025 Breakouts & Daily Price Action Insights - Улправда
Is Galecto Inc. stock supported by innovation pipeline2025 Risk Factors & Fast Gain Swing Alerts - ulpravda.ru
Should I hold or sell Galecto Inc. stock in 2025July 2025 Patterns & High Conviction Investment Ideas - ulpravda.ru
Galecto (NASDAQ:GLTO) Now Covered by Leerink Partners - Defense World
Leerink Partners Initiates Coverage of Galecto (GLTO) with Outperform Recommendation - Nasdaq
Leerink Partners Initiates Coverage on GLTO with 'Outperform' Ra - GuruFocus
Leerink Partners initiates coverage on Galecto stock with Outperform rating By Investing.com - Investing.com Australia
Leerink Partners initiates coverage on Galecto stock with Outperform rating - Investing.com
Galecto strengthens its leadership after recent acquisition in the US - medwatch.com
Galecto appoints former Blueprint Medicines executives as COO and CMO - MSN
Galecto Appoints Sherwin Sattarzadeh as Chief Operating Officer - marketscreener.com
Galecto appoints new chief operating officer, enhances leadership - TipRanks
Galecto announces key additions to leadership team - marketscreener.com
Galecto appoints Sherwin Sattarzadeh as chief operating officer and issues warrant - Investing.com
Galecto, Inc. Appoints New Chief Operating Officer - TradingView — Track All Markets
Galecto Announces Key Additions to Leadership Team - The Manila Times
Galecto (GLTO) grants large warrant and hires new Chief Operating Officer - Stock Titan
Galecto, Inc. Appoints Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer, Effective January 5, 2026 - marketscreener.com
Comparing Galecto (NASDAQ:GLTO) and Avidity Biosciences (NASDAQ:RNA) - Defense World
Is the Market Bullish or Bearish on Galecto Inc? - Benzinga
Will Galecto Inc stock pay special dividends2025 Historical Comparison & Growth-Oriented Investment Plans - Bộ Nội Vụ
Galecto Files to Register 60.5 Million Shares for Secondary Offering - marketscreener.com
GLTO SEC FilingsGalecto Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Galecto (NASDAQ:GLTO) Shares Down 13.3%Time to Sell? - MarketBeat
Galecto (NASDAQ:GLTO) Shares Down 13.3% – Time to Sell? - Defense World
[EFFECT] Galecto, Inc. SEC Filing - Stock Titan
Ideas Watch: Should I hold or sell Galecto Inc stock in 2025 - Bộ Nội Vụ
Why Galecto Inc. stock could benefit from AI revolution2025 Market WrapUp & Free Expert Approved Momentum Trade Ideas - Улправда
Galecto (GLTO) Price Target Increased by 12.50% to 36.72 - Nasdaq
How Galecto Inc. stock performs after earningsQuarterly Profit Summary & Reliable Breakout Forecasts - Улправда
How rising interest rates impact Galecto Inc. stock2025 Winners & Losers & Reliable Trade Execution Plans - DonanımHaber
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Galecto, Inc. announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Galecto (NASDAQ:GLTO) Price Target Raised to $36.00 at Guggenheim - Defense World
Guggenheim Maintains Galecto (GLTO) Buy Recommendation - Nasdaq
Guggenheim raises Galecto stock price target to $36 on positive ASH25 data - Investing.com Nigeria
Galecto (GLTO) Rating Maintained by Guggenheim, Price Target Rai - GuruFocus
Galecto (NASDAQ:GLTO) Upgraded to “Hold” at Wall Street Zen - Defense World
Galecto Inc (GLTO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Galecto Inc 주식 (GLTO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Winslow Garrett | General Counsel |
Jan 02 '26 |
Sale |
21.38 |
255 |
5,452 |
1,854 |
| Firmani Lori | Chief Financial Officer |
Jan 02 '26 |
Sale |
21.41 |
135 |
2,890 |
931 |
| Schambye Hans T. | Chief Executive Officer |
Jul 03 '25 |
Sale |
3.38 |
735 |
2,484 |
4,022 |
| Winslow Garrett | General Counsel |
Jul 03 '25 |
Sale |
3.39 |
260 |
881 |
1,429 |
| Firmani Lori | Interim CFO |
Jul 03 '25 |
Sale |
3.39 |
147 |
498 |
692 |
4.73%
0.92%
자본화:
|
볼륨(24시간):